Literature DB >> 6777010

Sodium valproate in schizophrenia: some biochemical correlates.

A Lautin, B Angrist, M Stanley, S Gershon, K Heckl, M Karobath.   

Abstract

Sodium valproate given in doses of 750-3000 mg daily to eight schizophrenic patients produced a qualitatively similar increase in symptoms in five. CSF showed no significant change in gamma-amino-butyric acid or methoxy hydroxyphenyl glycol, but homovanillic acid increased non-significantly in five patients.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6777010     DOI： 10.1192/bjp.137.3.240

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  4 in total

1.  High dose diazepam treatment and its effect on prolactin secretion in adolescent schizophrenic patients.

Authors:  A Weizman; S Tyano; H Wijsenbeek; M Ben David
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.

Authors:  Aurora Arrúe; Ricardo Dávila; Mercedes Zumárraga; Nieves Basterreche; Miguel A González-Torres; Biotza Goienetxea; Maria I Zamalloa; Juan B Anguiano; José Guimón
Journal:  Neurochem Res       Date:  2009-08-22       Impact factor: 3.996

3.  Low CSF GABA concentration in children with febrile convulsions, untreated epilepsy, and meningitis.

Authors:  D Rating; H Siemes; W Löscher
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

4.  High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients.

Authors:  J N Nestoros; N P Nair; J R Pulman; G Schwartz; D Bloom
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.